Kenponashi-Artichoke Compound Supplement’s Impact on Rats’ Chronic Hepatic Injury Caused by CCl4
Keywords:
Hepatitis, Chronic hepatitis, Artichoke extract, Kenponashi extract, Sanghuangporus sanghuang extract, Fructus schisandrae extract, Sesame extractAbstract
Background: Population aging is coupled with an increased morbidity rate of chronic diseases, and the lesions are mostly related to the liver, joints, and adipose tissues. Chronic diseases not only influence personal health but also increase national health and medical expenses. Non-alcoholic fatty liver disease (NAFLD) is the most familiar chronic liver disease (CLD) in the world. It will cause liver fibrosis or death without treatment, but there is no certified drug for treatment. According to many studies, artichoke (Cynara scolymus L.) extract, Kenponashi (Hoveniadulcis thunberg) extract, sanghuangporus sanghuang (Phellinuslinteus) extract, fructus schisandrae (Schisandra chinensis) extract, sesame (Sesamum indicum) extract, vitamin B complex and vitamin E have potential in resisting inflammation and liver fibrosis, but this novel combination for improving hepatic injury has not been studied or discussed in practice.
Objective: This experiment discussed the effect of an artichoke compound (AHC) formula containing artichoke extract, Kenponashi extract, sanghuangporus sanghuang extract, fructus schisandrae extract, sesame extract , vitamin B complex and vitamin E on improving the chronic hepatitis of rats induced by carbon tetrachloride(CCl4).
Design: A total of 50 six-week-old male Wistar rats were divided into five groups for use in the experiment, including the control group and four experimental groups (CCl4). The CCl4 groups were given carboxymethylcellulose (CMC) or AHC (318, 636 and 1,590 mg/kg, represented by AHC-L, AHC-M, and AHC-H, respectively). All rats were fed AHC for one week at first. Starting from the second week, the control group was fed olive oil (0.2 ml/100 g) per os, while the experimental group was fed with CCl4 20% twice per week for eight-weeks. During the experimental period, CMC or AHC was given to the rats once per day. All rats were sacrificed in the ninth-week to analyze their body weight, food intake, body fat content, serum biochemical value and liver lipids.
Results: The results showed that the final spleen weight of the CCl4+AHC-H group was significantly lower than that of the CCl4+CMC group; the AST concentration in the plasma of the CCl4+AHC-L, M and H groups was significantly lower than that of the CCl4 +CMC group; the ALT concentration in the plasma of the CCl4+AHC-H group was significantly lower than that of the CCl4+CMC group; the triglyceride and cholesterol concentrations in the plasma of the CCl4 +AHC-L, M and H groups were significantly lower than that of the CCl4+CMC group; the GSH concentration in the livers of the CCl4+AHC-L and H groups was significantly higher than that of the CCl4+CMC group; the hepatic fibrosis of the CCl4+AHC-L, M and H groups were significantly lower than that of the CCl4+CMC group (p<0.05).
Conclusion: AHC could reduce the ALT and AST values of rat plasma induced by CCl4, increase the antioxidant GSH content in the liver, and reduce the degree of hepatic fibrosis. It has the potential to be a natural and mild plant extract dietary supplement. Its long-term administration effect on the human body should be observed in the future.
References
Alt Y, Grimm A, Schlegel L, et al. The impact of liver cell in-jury on health-related quality of life in patients with chronic liver disease. PLoS One. 2016; 11(3): e0151200. doi: 10.1371/journal. pone.0151200
Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011; 9(6): 524-530.e1; quiz e60. doi: 10.1016/j.cgh.2011.03.020
Chen X, Ying X, Chen L, Zhang W, Zhang Y. Protective effects of sesamin on liver fibrosis through antioxidative and anti-in-flammatory activities in rats. Immunopharmacol Immunotoxicol. 2015; 37(5): 465-472. doi: 10.3109/08923973.2015.1085064
Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med. 2016; 164(11): 740-751. doi: 10.7326/M15-2650 Chu W-L, et al
Meng X, Li Y, Li S, et al. Dietary sources and bioactivities of melatonin. Nutrients. 2017; 9(4): 367. doi: 10.3390/nu9040367
Xu XY, Meng X, Li S, Gan RY, Li Y, Li HB. Bioactivity, health benefits, and related molecular mechanisms of curcumin: Current progress, challenges, and perspectives. Nutrients. 2018; 10(10): 1553. doi: 10.3390/nu10101553
Panahi Y, Kianpour P, Mohtashami R, et al. Efficacy of arti-choke leaf extract in non-alcoholic fatty liver disease: A pilot dou-ble-blind randomized controlled trial. Phytother Res. 2018; 32(7): 1382-1387. doi: 10.1002/ptr.6073
Lee M, Kim D, Park SJ, et al. Artichoke extract directly sup-presses inflammation and apoptosis in hepatocytes during the de-velopment of non-alcoholic fatty liver disease. J Med Food. 2021; 24(10): 1058-1067. doi: 10.1089/jmf.2021.K.0069
Kang KB, Jun JB, Kim JW, Kim HW, Sung SH. Ceanothane-and lupane-type triterpene esters from the roots of Hovenia dul-cis and their antiproliferative activity on HSC-T6 cells. Phytochem-istry. 2017; 142: 60-67. doi: 10.1016/j.phytochem.2017.06.014
Wang M, Jiang C, Ma L, et al. Preparation, preliminary char-acterization and immunostimulatory activity of polysaccharide fractions from the peduncles of Hovenia dulcis. Food Chem. 2013; 138(1): 41-47. doi: 10.1016/j.foodchem.2012.09.098
Kim H, Kim YJ, Jeong HY, et al. A standardized extract of the fruit of Hovenia dulcis alleviated alcohol- induced hangover in healthy subjects with heterozygous ALDH2: A randomized, controlled, crossover trial. J Ethnopharmacol. 2017; 209: 167-174. doi: 10.1016/j.jep.2017.07.028
Meng X, Tang GY, Zhao CN, Liu Q, Xu XY, Cao SY. Hep-atoprotective effects of Hovenia dulcis seeds against alcoholic liver injury and related mechanisms investigated via network pharmacology. World J Gastroenterol. 2020; 26(24): 3432-3446. doi: 10.3748/wjg.v26.i24.3432
Dai YC, Zhou LW, Cui BK, Chen YQ, Decock C. Current ad-vances in Phellinus sensu lato: medicinal species, functions, me-tabolites and mechanisms. Appl Microbiol Biotechnol. 2010; 87(5): 1587-1593. doi: 10.1007/s00253-010-2711-3
Chun JN, Cho M, So I, Jeon JH. The protective effects of Schisandra chinensis fruit extract and its lignans against cardio-vascular disease: A review of the molecular mechanisms. Fitotera-pia. 2014; 97: 224-233. doi: 10.1016/j.fitote.2014.06.014
Lu Y, Chen DF. Analysis of Schisandra chinensis and Schisan-dra sphenanthera. J Chromatogr A. 2009; 1216(11): 1980-1990. doi: 10.1016/j.chroma.2008.09.070
Panossian A, Wikman G. Pharmacology of Schisandra chi-nensis Bail.: An overview of Russian research and uses in medi-cine. J Ethnopharmacol. 2008; 118(2): 183-212. doi: 10.1016/j. jep.2008.04.020
Fan X, Chen P, Jiang Y, et al. Therapeutic efficacy of Wuzhi tablet (Schisandra sphenanthera Extract) on acetaminophen-in-duced hepatotoxicity through a mechanism distinct from N-acet-ylcysteine. Drug Metab Dispos. 2015; 43(3): 317-324. doi: 10.1124/ dmd.114.062067
Fan X, Jiang Y, Wang Y, et al. Wuzhi tablet (Schisandra Sphen-anthera extract) protects against acetaminophen-induced hepato-toxicity by inhibition of CYP-mediated bioactivation and regula-tion of NRF2-ARE and p53/p21 pathways. Drug Metab Dispos. 2014; 42(12): 1982-1990. doi: 10.1124/dmd.114.059535
Xie Y, Hao H, Wang H, Guo C, Kang A, Wang G. Reversing effects of lignans on CCl -induced hepatic CYP450 down regula-tion by attenuating oxidative stress. J Ethnopharmacol. 2014; 155(1): 213-221. doi: 10.1016/j.jep.2014.05.016
Liu CM, Zheng GH, Ming QL, Chao C, Sun JM. Sesamin pro-tects mouse liver against nickel-induced oxidative DNA damage and apoptosis by the PI3K-Akt pathway. J Agric Food Chem. 2013; 61(5): 1146-1154. doi: 10.1021/jf304562b
Bournival J, Francoeur MA, Renaud J, Martinoli MG. Querce-tin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res. 2012; 15(3): 322-333. doi: 10.1089/rej.2011.1242
Lee CC, Liu KJ, Wu YC, Lin SJ, Chang CC, Huang TS. Sesa-min inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangio-genic activity in breast cancer cells. Inflammation. 2011; 34(3): 209- 221. doi: 10.1007/s10753-010-9226-z
Wu XQ, Kong X, Zhou Y, Huang K, Yang JR, Li XL. Sesamin exerts renoprotective effects by enhancing NO bioactivity in re-novascular hypertensive rats fed with high-fat-sucrose diet. Eur J Pharmacol. 2012; 683(1-3): 231-237. doi: 10.1016/j. ejphar.2012.01.029
Peñalvo JL, Hopia A, Adlercreutz H. Effect of sesamin on se-rum cholesterol and triglycerides levels in LDL receptor-deficient mice. Eur J Nutr. 2006; 45(8): 439-444. doi: 10.1007/s00394-006- 0617-8
Chang CY, Chen YL, Yang SC, et al. Effect of schisandrin B and sesamin mixture on CCl(4)-induced hepatic oxidative stress in rats. Phytother Res. 2009; 23(2): 251-256. doi: 10.1002/ptr.2602
Ma JQ, Ding J, Zhang L, Liu CM. Hepatoprotective proper-ties of sesamin against CCl induced oxidative stress-mediated apoptosis in mice via JNK pathway. Food Chem Toxicol. 2014; 64: 41-48. doi: 10.1016/j.fct.2013.11.017
Hou RC, Chen HL, Tzen JT, Jeng KC. Effect of sesame anti-oxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport. 2003; 14(14): 1815-1819. doi: 10.1097/00001756- 200310060-00011 16 Chu W-L, et al
Phitak T, Pothacharoen P, Settakorn J, Poompimol W, Cater-son B, Kongtawelert P. Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry. 2012; 80: 77-88. doi: 10.1016/j. phytochem.2012.05.016
Abdulkhaleq FM, Alhussainy TM, Badr MM, et al. Antioxida-tive stress effects of vitamins C, E, and B12, and their combina-tion can protect the liver against acetaminophen-induced hepa-totoxicity in rats. Drug Des Devel Ther. 2018; 12: 3525-3533. doi: 10.2147/DDDT.S172487
Podszun MC, Frank J. Impact of vitamin E on redox bio-markers in non-alcoholic fatty liver disease. Redox Biol. 2021; 42: 101937. doi: 10.1016/j.redox.2021.101937
Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976; 74(1): 214-226. doi: 10.1016/0003-2697(76)90326-2
Neuman RE, Logan MA. The determination of hydroxypro-line. J Biol Chem. 1950; 184(1): 299-306.
Folch J, Lees M, Stanley GHS. A simple method for the iso-lation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226(1): 497-509. doi: 10.1016/S0021-9258(18)64849-5
Xia E, Rao G, Van Remmen H, Heydari AR, Richardson A. Activities of antioxidant enzymes in various tissues of male Fischer 344 rats are altered by food restriction. J Nutr. 1995; 125(2): 195-201. doi: 10.1093/jn/125.2.195
Aebi H. Catalase in vitro. Methods Enzymol. 1984; 105: 121-126. doi: 10.1016/s0076-6879(84)05016-3
Sturgill MG, Lambert GH. Xenobiotic-induced hepatotoxici-ty: Mechanisms of liver injury and methods of monitoring hepat-ic function. Clin Chem. 1997; 43(8 Pt 2): 1512-1526. doi: 10.1093/ clinchem/43.8.1512
Vandenberghe J. Hepatotoxicology: Mechanisms of liver tox-icity and methodological aspects. In: Niesink RJM, De Vries J, Hollinger MA, eds. Toxicology: Principle and Applications. NY, USA: CRC Press; 1996: 703-723.
Gill MA, Kircbain WR. Alcoholic liver disease. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Poser LM, eds. Phar-macotherapy: A Pathophysi-ologic Approach. 3rd ed. Appleton & Lange Stamford; 1997: 785-800.
Hanauske-Abel HM. Fibrosis: Representive molecular ele-ments, a basic concept, and emerg-ing targets for suppressive treatment. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. 3rd ed. W.B. Philadelphia, Pennsylvania: Saunders Company; 1996: 465-506.
DeLeve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther. 1991; 52(3): 287-305. doi: 10.1016/0163-7258(91)90029-l
Huang ZZ, Li H, Cai J, Kuhlenkamp J, Kaplowitz N, Lu SC. Changes in glutathione homeostasis during liver regenera-tion in the rat. Hepatology. 1998; 27(1): 147-153. doi: 10.1002/ hep.510270123
Du J, He D, Sun LN, et al. Semen Hoveniae extract protects against acute alcohol-induced liver injury in mice. Pharm Biol. 2010; 48(8): 953-958. doi: 10.3109/13880200903300196
Rangboo V, Noroozi M, Zavoshy R, Rezadoost SA, Moham-madpoorasl A. The effect of artichoke leaf extract on alanine aminotransferase and aspartate aminotransferase in the patients with nonalcoholic steatohepatitis. Int J Hepatol. 2016; 2016: 4030476. doi: 10.1155/2016/4030476
Hase K, Ohsugi M, Xiong Q, Basnet P, Kadota S, Namba T. Hepatoprotective effect of Hovenia dulcis THUNB. on ex-perimental liver injuries induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Biol Pharm Bull. 1997; 20(4): 381-385. doi: 10.1248/bpb.20.381
Wang H, Wu G, Park HJ, et al. Protective effect of Phelli-nus linteus polysaccharide extracts against thioacetamide-induced liver fibrosis in rats: A proteomics analysis. Chin Med. 2012; 7(1): 23. doi: 10.1186/1749-8546-7-23
Zhao L, Zheng L, Li Z, et al. Phellinus linteus polysaccharides mediates acetaminophen-induced hepatotoxicity via activating AMPK/Nrf2 signaling pathways. Aging (Albany NY). 2022; 14(17): 6993-7002. doi: 10.18632/aging.204260 Submit your article to this journal | https://openventio.org/submit-manuscript/ Chu W-L, et al
Che J, Yang S, Qiao Z, et al. Schisandra chinensis acidic poly-saccharide partialy reverses acetaminophen-induced liver injury in mice. J Pharmacol Sci. 2019; 140(3): 248-254. doi: 10.1016/j. jphs.2019.07.008
Wang CM, Yuan RS, Zhuang WY, et al. Schisandra polysac-charide inhibits hepatic lipid accumulation by downregulating ex-pression of SREBPs in NAFLD mice. Lipids Health Dis. 2016; 15(1): 195. doi: 10.1186/s12944-016-0358-5
Yuan R, Tao X, Liang S, et al. Protective effect of acidic poly-saccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress. Biomed Pharmacother. 2018; 99: 537-542. doi: 10.1016/j.bio-pha.2018.01.079
Yang Y, Wang J, Zhang Y, Li J, Sun W. Black sesame seeds ethanol extract ameliorates hepatic lipid accumulation, oxidative stress, and insulin resistance in fructose-induced nonalcoholic fatty liver disease. J Agric Food Chem. 2018; 66(40): 10458-10469. doi: 10.1021/acs.jafc.8b04210
Lv D, Zhu CQ, Liu L. Sesamin ameliorates oxidative liver injury induced by carbon tetrachloride in rat. Int J Clin Exp Pathol. 2015; 8(5): 5733-5738.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Liver Research (LROJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.